Mickey Koh

5.5k total citations · 2 hit papers
86 papers, 2.6k citations indexed

About

Mickey Koh is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Mickey Koh has authored 86 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hematology, 30 papers in Oncology and 25 papers in Immunology. Recurrent topics in Mickey Koh's work include Hematopoietic Stem Cell Transplantation (31 papers), Immune Cell Function and Interaction (18 papers) and CAR-T cell therapy research (12 papers). Mickey Koh is often cited by papers focused on Hematopoietic Stem Cell Transplantation (31 papers), Immune Cell Function and Interaction (18 papers) and CAR-T cell therapy research (12 papers). Mickey Koh collaborates with scholars based in United Kingdom, Singapore and United States. Mickey Koh's co-authors include Thierry Burnouf, Katharina Schallmoser, Dirk Strunk, Massimo Dominici, Garnet Suck, Beverley J. Hunt, Christian Gabriel, Reinhard Henschler, Mark W. Lowdell and H. G. Prentice and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Mickey Koh

81 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Defining mesenchymal stromal cell (MSC)‐derived small extracellular vesicles for therapeutic applications

2019 462 citations Kenneth W. Witwer, Bas W. M. van Balkom et al. Journal of Extracellular Vesicles profile →
Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation?

2015 391 citations Mickey Koh et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mickey Koh United Kingdom	26	720	719	717	597	482	86	2.6k
Wichard Vogel Germany	27	561 0.8×	519 0.7×	697 1.0×	631 1.1×	563 1.2×	103	2.5k
Fermín Sánchez‐Guijo Spain	37	1.2k 1.7×	581 0.8×	1.3k 1.8×	2.0k 3.4×	644 1.3×	146	4.3k
Morris Kletzel United States	29	922 1.3×	337 0.5×	974 1.4×	474 0.8×	479 1.0×	148	3.1k
Hadi Goubran Canada	26	709 1.0×	216 0.3×	736 1.0×	213 0.4×	491 1.0×	71	2.5k
Tomasz Szczepański Poland	35	785 1.1×	705 1.0×	1.8k 2.5×	674 1.1×	584 1.2×	168	4.1k
Lisbeth Barkholt Sweden	30	502 0.7×	711 1.0×	1.2k 1.7×	1.0k 1.8×	917 1.9×	82	3.8k
Sarah J. Glennie United Kingdom	16	707 1.0×	691 1.0×	453 0.6×	2.1k 3.6×	414 0.9×	23	3.2k
Alessandro Busca Italy	30	1.1k 1.5×	682 0.9×	1.1k 1.5×	991 1.7×	814 1.7×	152	4.0k
Dagmar Dilloo Germany	29	1.2k 1.6×	1.4k 1.9×	1.1k 1.5×	1.5k 2.5×	1.4k 3.0×	92	4.7k
Werner Linkesch Austria	40	1.6k 2.2×	536 0.7×	1.9k 2.6×	1.6k 2.7×	1.6k 3.2×	184	5.6k

Countries citing papers authored by Mickey Koh

Since Specialization

Citations

This map shows the geographic impact of Mickey Koh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mickey Koh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mickey Koh more than expected).

Fields of papers citing papers by Mickey Koh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mickey Koh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mickey Koh. The network helps show where Mickey Koh may publish in the future.

Co-authorship network of co-authors of Mickey Koh

This figure shows the co-authorship network connecting the top 25 collaborators of Mickey Koh. A scholar is included among the top collaborators of Mickey Koh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mickey Koh. Mickey Koh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matas, Arthur J., Mickey Koh, Lydia Foeken, et al.. (2025). Similarities and Differences Between Allogeneic Hematopoietic Cell and Organ Transplantation and What We Can Learn From Each Other to Guide Global Health Strategy. Clinical Transplantation. 39(10). e70346–e70346.

Dadheech, Nidheesh, Eddie Han Pin Tan, Natasha Hui Jin Ng, et al.. (2025). Stem cell therapies for diabetes. Nature Medicine. 31(7). 2147–2160. 1 indexed citations

Linn, Yeh Ching, et al.. (2023). A cost-effective strategy for selection of third-party donors for a virus-specific T-cell bank for an Asian patient population. Cytotherapy. 25(5). 510–520.

Sugrue, Michele W., Jay S. Raval, Kevin J. Land, et al.. (2020). Adverse event reporting for cellular therapy products: Current status and future directions. Transfusion. 60(12). 2815–2827. 2 indexed citations

Worel, Nina, Bronwen E. Shaw, Mahmoud Aljurf, et al.. (2020). Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation. Transplantation and Cellular Therapy. 27(3). 270.e1–270.e6. 13 indexed citations

Witwer, Kenneth W., Bas W. M. van Balkom, Stefania Bruno, et al.. (2019). Defining mesenchymal stromal cell (MSC)‐derived small extracellular vesicles for therapeutic applications. Journal of Extracellular Vesicles. 8(1). 1609206–1609206. 462 indexed citations breakdown →

Miller, P.D., John A. Snowden, Régis Peffault de Latour, et al.. (2019). Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation. 55(2). 441–451. 19 indexed citations

Robinson, Stephen, Ariane Boumendil, Karl S. Peggs, et al.. (2018). Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party. Bone Marrow Transplantation. 53(5). 617–624. 34 indexed citations

Diong, Colin Phipps, S. Gopalakrishnan, Aloysius Ho, et al.. (2016). An exploration of the applicability of the refined disease risk index and its integration with other independent risk factors for individualized prognostication. Bone Marrow Transplantation. 52(3). 363–371. 3 indexed citations

10.

Keever-Taylor, Carolyn A., Dietger Niederwieser, Takanori Teshima, et al.. (2014). Essential requirements for setting up a stem cell processing laboratory. Bone Marrow Transplantation. 49(8). 1098–1105. 16 indexed citations

11.

Marsh, Judith, Vikas Gupta, ZiYi Lim, et al.. (2011). Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia. Blood. 118(8). 2351–2357. 105 indexed citations

12.

Suck, Garnet, et al.. (2011). Interleukin-15 supports generation of highly potent clinical-grade natural killer cells in long-term cultures for targeting hematological malignancies. Experimental Hematology. 39(9). 904–914. 30 indexed citations

13.

Linn, Yeh Ching, et al.. (2011). Clinical scale expansion of cytokine-induced killer cells is feasible from healthy donors and patients with acute and chronic myeloid leukemia at various stages of therapy. Experimental Hematology. 39(9). 897–903.e1. 22 indexed citations

14.

Suck, Garnet & Mickey Koh. (2010). Emerging natural killer cell immunotherapies. Hematology/Oncology and Stem Cell Therapy. 3(3). 135–142. 26 indexed citations

15.

Babatunde, Abiola, Daryl Tan, Yvonne Loh, et al.. (2009). Characterization of hemopoietic engraftment kinetics and development of secondary cytopenia in AML post auto-SCT and its correlation with survival outcome. Bone Marrow Transplantation. 44(3). 175–183. 2 indexed citations

16.

Ang, Ai Leen, et al.. (2008). Blood transfusion requirements and independent predictors of increased transfusion requirements among adult patients on extracorporeal membrane oxygenation – a single centre experience. Vox Sanguinis. 96(1). 34–43. 58 indexed citations

17.

Tan, Daryl, Li Yang Hsu, Liang Piu Koh, Yeow Tee Goh, & Mickey Koh. (2005). Severe conidiobolomycosis complicating induction chemotherapy in a patient with acute lymphoblastic leukaemia. British Journal of Haematology. 129(4). 447–447. 7 indexed citations

18.

Deane, Miriam, Mickey Koh, Letizia Foroni, et al.. (1998). FLAG-idarubicin and allogeneic stem cell transplantation for Ph-positive ALL beyond first remission. Bone Marrow Transplantation. 22(12). 1137–1143. 19 indexed citations

19.

Koh, Mickey, et al.. (1997). Selective depletion of alloreactive lymphoctyes in HLA matched pairs. UCL Discovery (University College London). 2 indexed citations

20.

Koh, Mickey, et al.. (1996). Selective removal of alloreactive lymphocytes from peripheral blood mononuclear cell preparations.. UCL Discovery (University College London). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact